Kimia Biosciences Limited reported earnings results for the fourth quarter and full year ended March 31, 2023. For the fourth quarter, the company reported sales was INR 226.63 million compared to INR 298.81 million a year ago. Revenue was INR 230.26 million compared to INR 301 million a year ago. Net loss was INR 61.65 million compared to INR 14.08 million a year ago. Basic loss per share from continuing operations was INR 1.3 compared to INR 0.3 a year ago. Diluted loss per share from continuing operations was INR 1.3 compared to INR 0.3 a year ago.
For the full year, sales was INR 1,285.16 million compared to INR 1,249.01 million a year ago. Revenue was INR 1,297.29 million compared to INR 1,258.33 million a year ago. Net loss was INR 93.52 million compared to INR 37.03 million a year ago. Basic loss per share from continuing operations was INR 1.98 compared to INR 0.73 a year ago. Diluted loss per share from continuing operations was INR 1.98 compared to INR 0.73 a year ago.